Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Go back to Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial| (NASDAQ: CMND) | Delayed: 0.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $ | |||
| Open | $0.74 | 52 Week Low | $ | |||
| Day High | $0.74 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $ | |||
| Volume | 100,887 | |||||
